Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors
Joseph Song(Icahn School of Medicine at Mount Sinai), Kambiz Nael(University of California, San Francisco), Amanda Kravitz(Icahn School of Medicine at Mount Sinai), Priyanka Kadaba(Icahn School of Medicine at Mount Sinai), Puneet Belani(Icahn School of Medicine at Mount Sinai), Costas G. Hadjipanayis(Emory University), Adı́lia Hormigo(Icahn School of Medicine at Mount Sinai), Joshua Friedman(Icahn School of Medicine at Mount Sinai), Benjamin M. Ellingson(University of California, Los Angeles)
Cited by 44
Related Papers
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
|Neuro-Oncology|2015|665
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
|Neuro-Oncology|2020|258
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas
|Neuro-Oncology|2020|190
Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
|Oncotarget|2015|140
Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent <i>IDH</i> wild-type glioblastoma
|Neuro-Oncology Advances|2022|61